thalidomide has been researched along with Encephalitozoonosis in 1 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Encephalitozoonosis: Infection with FUNGI of the genus ENCEPHALITOZOON. Lesions commonly occur in the BRAIN and KIDNEY tubules. Other sites of infection in MAMMALS are the LIVER; ADRENAL GLANDS; OPTIC NERVES; RETINA; and MYOCARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thalidomide was evaluated for its in vitro activity against Encephalitozoon species by using the MRC-5 cell system." | 2.40 | Lack of in vitro antimicrosporidian activity of thalidomide. ( Drancourt, M; Ridoux, O, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ridoux, O | 1 |
| Drancourt, M | 1 |
1 review available for thalidomide and Encephalitozoonosis
| Article | Year |
|---|---|
Lack of in vitro antimicrosporidian activity of thalidomide.
Topics: AIDS-Related Opportunistic Infections; Analysis of Variance; Animals; Anti-HIV Agents; Dose-Response | 1999 |